Myocardial Infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with myocardial infarction according to the American College of Cardiology criteria Consent to enter the study Age over 18 years Not suffering from kidney failure under hemodialysis Absence of kidney failure and GFR<30 Absence of severe liver failure with liver enzymes more than 3 times normal Not taking Vitamin E
Exclusion criteria
Exclusion criteria: Lack of consent to continue studying
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in hs-CRP serum levels. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile changes. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.;CBC level changes diff. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences